TOP TIERMARKET NEWSWIRE

News & sentiment

ARGENX SE ADR (ARGX) — News & AI sentiment

ARGENX SE ADR (ARGX) news roundup. 2 stories in the last 24 hours, 35 in the past week, 43 over 30 days. Average 24-hour sentiment is 56/100 — neutral (50 is neutral). No insider transactions filed in the last 90 days. US House Periodic Transaction Reports (90-day window): 1 purchase (~$8K) and 0 sales (~$0). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

2

avg sentiment 56/100

7d stories

35

avg sentiment 65.4/100

30d stories

43

avg sentiment 64.4/100

Insider net (90d)

$0

0 buys · 0 sells

Congress (90d)

1

1 buys · 0 sells

Latest stories on ARGX

Health Care Roundup: Market Talk

WSJ Markets50 · neutralgeneral

19h ago

argenx: Upgrading To Buy, The VYVGART Growth Cycle Has Further To Go

Seeking Alpha73 · bullishanalyst

1d ago

Argenx stock price target held at $940 by H.C. Wainwright on acquisition

Investing.com Analyst Ratings56 · neutralanalyst

2d ago

argenx signs agreement to buy Forte Biosciences for $2.2bn

Yahoo Top62 · neutralm&a

2d ago

argenx signs agreement to buy Forte Biosciences for $2.2bn

Yahoo Finance62 · neutralm&a

2d ago

Forte: 'Hold' On Positive FB102 Vitiligo Treatment Data And argenx Acquisition For $2.2 Billion

Seeking Alpha56 · neutralm&a

3d ago

Forte Biosciences shares surge after argenx agrees to acquire company for $2.2B

Yahoo Top78 · bullishm&a

3d ago

argenx To Acquire Forte Biosciences: What Investors Should Know

Seeking Alpha52 · neutralm&a

3d ago

argenx Strikes $2.2B Deal for Forte, Adds Autoimmune Drug FB102

Yahoo Top67 · bullishm&a

3d ago

argenx Acquisition of Forte Biosciences Highlights Strategic Expansion in Immunology With $2.2 Billion Deal July 27, 2026

MarketChameleon73 · bullishm&a

3d ago

M&A News: Forte Biosciences Shares Leap 40% After Argenx Seals $2.2B Immunology Deal

TipRanks73 · bullishm&a

3d ago

Argenx to acquire Forte in $2.2B deal for ‘differentiated’ immune drug

Yahoo Finance63 · neutralm&a

3d ago

Argenx to Buy Forte Biosciences for $2.2 Billion

Morningstar63 · neutralm&a

3d ago

Forte Biosciences stock surges 39% on argenx acquisition deal

Investing.com Markets73 · bullishm&a

3d ago

FBRX Stock On Track For Highest Levels In Over 4.5 Years As ArgenX Scoops Up Autoimmune Drug Maker

Stocktwits News67 · bullishm&a

3d ago

argenx Acquires Forte Biosciences for $2.2 Billion, Expanding Its Immunology Pipeline with First-in-Class FB102 July 27, 2026

MarketChameleon73 · bullishm&a

3d ago

Forte Biosciences shares jump after $2.2 billion takeover agreement with argenx

Yahoo Finance88 · bullishm&a

3d ago

Forte Biosciences shares jump after $2.2 billion takeover agreement with argenx

InvestorsHub73 · bullishm&a

3d ago

Argenx agrees $2.2 billion acquisition of Forte Biosciences to strengthen autoimmune drug pipeline

Yahoo Finance63 · neutralm&a

3d ago

Argenx agrees $2.2 billion acquisition of Forte Biosciences to strengthen autoimmune drug pipeline

InvestorsHub63 · neutralm&a

3d ago

Forte Biosciences to be acquired by argenx

TipRanks73 · bullishm&a

3d ago

Forte Biosciences Shares Leap Premarket on Takeover by Argenx

Morningstar82 · bullishm&a

3d ago

Biggest stock movers Monday: AVGO, FBRX, oil companies, and more

Seeking Alpha58 · neutralgeneral

3d ago

argenx strikes $2.2B deal for Forte Biosciences

Seeking Alpha68 · bullishm&a

3d ago

Argenx to buy Forte Biosciences for $2.2 billion to expand immunology pipeline

Investing.com Markets63 · neutralm&a

3d ago

Open ARGX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →